|
NMNAT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62547753035369E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-16 |
| Normal-vs-Stage2 |
1.313640E-02 |
| Normal-vs-Stage3 |
8.64086580065759E-13 |
| Normal-vs-Stage4 |
1.11022302462516E-16 |
| Stage1-vs-Stage2 |
2.044100E-03 |
| Stage1-vs-Stage3 |
1.304970E-01 |
| Stage1-vs-Stage4 |
1.044780E-03 |
| Stage2-vs-Stage3 |
1.046400E-04 |
| Stage2-vs-Stage4 |
1.11609999997597E-06 |
| Stage3-vs-Stage4 |
7.740500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.62500000000509E-06 |
| Normal-vs-Asian |
6.99429958395115E-10 |
| Caucasian-vs-AfricanAmerican |
5.217200E-01 |
| Caucasian-vs-Asian |
8.841200E-01 |
| AfricanAmerican-vs-Asian |
6.222600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.74966765707086E-13 |
| Normal-vs-Female |
1.63169477929159E-12 |
| Male-vs-Female |
4.372000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
6.86606327349182E-12 |
| Normal-vs-Age(61-80Yrs) |
1.86199999863135E-09 |
| Normal-vs-Age(81-100Yrs) |
9.81890000000263E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.129200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.721800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.184600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.799000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.590400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.441800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.62899999994948E-06 |
| Classical-VS-Follicular |
1.4073999999864E-06 |
| Classical-VS-Other |
7.280600E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.80822024020699E-12 |
| Tall-VS-Other |
2.902800E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
7.139700E-02 |
| Follicular-VS-Normal |
1.124040E-03 |
| Other-VS-Normal |
3.014000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.7551000087177E-09 |
| Normal-vs-N1 |
1.62436730732907E-12 |
| N0-vs-N1 |
9.89850001964498E-09 |
|
|
